Potent Human Immunodeficiency Virus Type 1 Protease Inhibitors That Utilize Noncoded d-Amino Acids as P2/P3 Ligands
- 1 January 1996
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 39 (1) , 96-108
- https://doi.org/10.1021/jm950576c
Abstract
Noncoded d-amino acids have been designed to replace the quinaldic amide−asparaginyl moiety (P2/P3 ligand) found in several potent human immunodeficiency virus (HIV) protease inhibitors such as LY289612. The substituted nitrogen, optimally an N-methanesulfonyl moiety, served as a CH2CONH2 (asparagine side chain mimic), while the amino acid side chain became the backbone and P3 ligand of these novel inhibitors. Compounds derived from S-aryl-d-cysteine proved to be potent HIV protease inhibitors which also exhibited potent whole cell antiviral activity. Oxidation of the cysteines to the sulfoxide or sulfone oxidation states resulted in significant improvements in potency. For example, the compound derived from N-(methylsulfonyl)-2-S-naphthylcysteine sulfone, 17c, was a 3.5 nM inhibitor of HIV protease which inhibited the spread of virus in MT4 cells with an IC50 = 4.3 nM. Compounds 17c,g,i were found to be orally bioavailable in a rat model.Keywords
This publication has 12 references indexed in Scilit:
- L-735,524: The Design of a Potent and Orally Bioavailable HIV Protease InhibitorJournal of Medicinal Chemistry, 1994
- New dipeptide isosteres useful for the inhibition of HIV-1 proteaseBioorganic & Medicinal Chemistry Letters, 1994
- D-amino acids as novel P2/P3 ligands for inhibitors of HIV-1 proteaseBioorganic & Medicinal Chemistry Letters, 1994
- Discovery of a novel class of potent HIV-1 protease inhibitors containing the (R)-(hydroxyethyl)urea isostereJournal of Medicinal Chemistry, 1993
- (D) Routes of delivery: Case studies: (5) Oral absorption of peptides and proteinsAdvanced Drug Delivery Reviews, 1992
- The HIV-1 Protease as a Therapeutic Target for AIDSAIDS Research and Human Retroviruses, 1992
- Immunobiology and Pathogenesis of Hepatocellular Injury in Hepatitis B Virus Transgenic MiceScience, 1990
- New Soluble-Formazan Assay for HIV-1 Cytopathic Effects: Application to High-Flux Screening of Synthetic and Natural Products for AIDS-Antiviral ActivityJNCI Journal of the National Cancer Institute, 1989
- A novel approach to the synthesis of optically pure non protein α-amino acids in both L and D configurations from L-serineTetrahedron Letters, 1987
- Role of agostic interaction in .beta.-elimination of palladium and nickel complexes. An ab initio MO studyJournal of the American Chemical Society, 1985